Plasmodium falciparum malaria vaccine (University of Oxford/European and Developing Countries Clinical Trials Partnership/Medical Research Council Unit The Gambia at the LSHTM)

N/A

Report date: 2025/01/26 17:45:15

Base Information

Drug NamePlasmodium falciparum malaria vaccine (University of Oxford/European and Developing Countries Clinical Trials Partnership/Medical Research Council Unit The Gambia at the LSHTM)
Drug Alias NameRH-5.2 VLP
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomBurkina FasoGambia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A